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A mitotic topoisomerase II checkpoint
in budding yeast is required for genome
stability but acts independently
of Pds1/securin
Catherine A. Andrews,1,3 Amit C. Vas,1,3 Brian Meier,1,3 Juan F. Giménez-Abián,1,2
Laura A. Díaz-Martínez,1 Julie Green,1 Stacy L. Erickson,1 Kristyn E. VanderWaal,1 Wei-Shan Hsu,1
and Duncan J. Clarke1,4
1Department of Genetics, Cell Biology and Development, University of Minnesota Medical School, Minneapolis, Minnesota
55455, USA; 2Proliferación Celular, Centro de Investigaciones Biológicas, 28040 Madrid, Spain
Topoisomerase II (Topo II) performs topological modifications on double-stranded DNA molecules that are
essential for chromosome condensation, resolution, and segregation. In mammals, G2 and metaphase cell
cycle delays induced by Topo II poisons have been proposed to be the result of checkpoint activation in
response to the catenation state of DNA. However, the apparent lack of such controls in model organisms has
excluded genetic proof that Topo II checkpoints exist and are separable from the conventional DNA damage
checkpoint controls. But here, we define a Topo II-dependent G2/M checkpoint in a genetically amenable
eukaryote, budding yeast, and demonstrate that this checkpoint enhances cell survival. Conversely, a lack of
the checkpoint results in aneuploidy. Neither DNA damage-responsive pathways nor Pds1/securin are needed
for this checkpoint. Unusually, spindle assembly checkpoint components are required for the Topo II
checkpoint, but checkpoint activation is not the result of failed chromosome biorientation or a lack of spindle
tension. Thus, compromised Topo II function activates a yeast checkpoint system that operates by a novel
mechanism.
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Type-II DNA topoisomerases are essential conserved en-
zymes (DiNardo et al. 1984; Uemura and Yanagida 1984;
Holm et al. 1985) abundant in interphase nuclei and ma-
jor components of mitotic chromosomes (Earnshaw et al.
1985; Hirano and Mitchison 1991; Giménez-Abián et al.
1995). Topoisomerase II (Topo II) homodimers perform
an ATP-dependent “strand-passage” reaction in which
one double-stranded DNA (dsDNA) molecule is trans-
ported through a second, transiently cut dsDNA mol-
ecule. This unique cycle of DNA breakage, transport,
and religation, which reversibly decatenates dsDNA
and modulates supercoiling, is essential for mitosis
(Yanagida and Wang 1987). It prepares chromosomes for
segregation by unknotting all of the DNA molecules in
the cell that inevitably became concatenated as a conse-
quence of their replication (Cook 1991).
Decatenation must be coordinated with cell cycle pro-
gression. In G2 and early mitosis, removal of intra- and
interchromosomal catenations allows chromosome indi-
vidualization (Giménez-Abián et al. 2000) and conden-
sation (Newport 1987; Charron and Hancock 1990;
Wood and Earnshaw 1990; Adachi et al. 1991; Hirano and
Mitchison 1991; Giménez-Abián et al. 1995; Giménez-
Abián and Clarke 2003). From the end of prophase, fur-
ther decatenation allows sisters to become resolved,
then segregate from one another in anaphase (Sundin and
Varshavsky 1981; Wasserman and Cozzarelli 1986;
Shamu and Murray 1992; Clarke et al. 1993; Downes et
al. 1994; Giménez-Abián et al. 1995).
Not surprisingly, cell cycle progression in the absence
of Topo II results in mitotic catastrophe. Thus, it has
been proposed that biochemical surveillance systems, or
checkpoints, control mitosis in response to the decatena-
tory activity of Topo II (Downes et al. 1994; Gimenez-
Abian et al. 2002). Checkpoints monitor the progress of
particular cellular processes (e.g., DNA replication), then
send signals that restrain the cell cycle machinery and
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thereby inhibit the transition to the next cell cycle stage
until these processes are complete (Clarke and Giménez-
Abián 2000). In this way, the cell cycle proceeds by an
ordered series of processes. However, checkpoints are
rarely so robust as to maintain cell cycle arrest. Rather,
checkpoints are typically transient cell cycle delays that
aim to allow some extra time for the process being moni-
tored to become complete.
Treating mammalian G2 cells with Topo II inhibitors
delays entry into mitosis (Kalwinsky et al. 1983) and
checkpoint-evading agents such as caffeine bypass these
delays (Downes et al. 1994). Thus, it was reasoned that
this effect was due to a G2 checkpoint system that moni-
tors Topo II activity or the catenation state of DNA. This
putative G2 checkpoint was proposed to be distinct from
the G2 DNA damage checkpoint, because the Topo II
inhibitors used, such as ICRF-193, induced G2 delays
without directly causing DNA strand breaks (Creighton
and Birnie 1969; Tanabe et al. 1991; Downes et al. 1994).
However, recent studies did detect DNA damage in-
duced by these drugs, most likely generated indirectly as
a consequence of interrupted decatenation, indicating
that an overlap between G2 damage and Topo II check-
points may exist (Dominguez et al. 2001; Mikhailov et
al. 2002; Hajji et al. 2003; Adachi et al. 2004). Other work
has implicated DNA damage response proteins (ATR,
Brca1, and Ku) (Deming et al. 2001; Munoz et al. 2001)
and the p38 pathway (Mikhailov et al. 2004) in Topo II
checkpoint function. The Topo II inhibitor ICRF-193 has
also been reported to delay the cell cycle at the meta-
phase-to-anaphase transition (Mikhailov et al. 2002; Sk-
oufias et al. 2004), but whether this delay is due to Topo
II inhibition (Skoufias et al. 2004) or to DNA breakage
(Mikhailov et al. 2002) remains unresolved.
The cellular pathways that enforce these G2 and meta-
phase cell cycle delays have not been defined rigorously
in genetic terms. Other eukaryotic checkpoint controls,
the G1 and G2 DNA damage and the spindle assembly
checkpoints, have been proven to exist by genetic means
and have been rapidly characterized owing to their de-
tailed study in lower eukaryotes, primarily yeasts. In
budding and fission yeast, the essential role of Topo II in
decatenating sister chromatids before anaphase has been
demonstrated by means of temperature-sensitive top2
mutants (DiNardo et al. 1984; Uemura and Yanagida
1984; Holm et al. 1985; Uemura et al. 1986). However, at
the nonpermissive temperature, top2 cells have been re-
ported to progress through mitosis without delay. In fact,
the apparent lack of a Topo II checkpoint in any model
system has impeded an exhaustive characterization of
this critical checkpoint.
We sought genetic proof that Topo II checkpoints
function to protect the genome, and report here the iden-
tification of a Topo II checkpoint in budding yeast. We
have characterized top2 mutant strains that delay cell
cycle progression such that G2/M lasts over three times
its normal duration. As expected, a failure of this check-
point response causes aneuploidy and reduces cell viabil-
ity, but most interesting is that this Topo II checkpoint
enforces its G2/M delay via an entirely unexpected
mechanism. The checkpoint response does not rely on
DNA damage checkpoint components, but rather it uses
a subset of the spindle checkpoint proteins. However,
the Topo II checkpoint is distinct from the conventional
spindle checkpoint in two important ways; firstly, it is
not activated in response to spindle damage or a lack of
chromosome biorientation/tension, and secondly, it
does not act by Pds1-dependent inhibition of Esp1/sepa-
rase. Thus, the Topo II-dependent checkpoint defined
herein is distinct from the known checkpoint systems.
Results
G2/M delay in top2-B44, a hypomorphic mutant
of TOP2
Evidence that budding yeast cells lack a Topo II-depen-
dent checkpoint comes from studies using the top2-4
allele that fails to delay mitosis at the nonpermissive
temperature. Still, there are cases where mutations
cause a “checkpoint-active” situation to arise, but si-
multaneously render checkpoint signaling ineffectual.
One example is the lack of a DNA replication check-
point signal in mutants that prevent replication origin
firing. Based on this premise, we isolated new tempera-
ture-sensitive TOP2 alleles and assayed whether these
mutations induced a cell cycle delay. Cells were released
from G1 synchrony induced by mating pheromone, then
samples were taken at intervals to score budding, spindle
morphologies, and for FACScan analysis of DNA con-
tent. In wild-type cells, the interval between spindle as-
sembly and anaphase (spindle elongation) was 14.8 ± 3.2
min (n = 14 experiments) (Fig. 1A; see Materials and
Methods for calculations). Since spindle assembly is ap-
proximately coincident with the completion of DNA
replication, we used the spindle assembly-to-spindle
elongation interval as an estimate of the length of G2/M
phase. (Note that in budding yeast, cell cycle stages be-
tween G2 and metaphase are indistinguishable cytologi-
cally, because the chromosomes become bioriented—the
classical definition of metaphase—around the time that
DNA replication is completed.)
In the top2 mutants described herein, budding, spindle
assembly, and DNA replication occurred with kinetics
indistinguishable from wild type (Fig. 1; data not shown).
As previously reported, top2-4 mutants did not delay
anaphase at the nonpermissive temperature of 32°C (Fig.
1A), but spindle elongation was blocked by expression of
nondegradable securin (Clarke et al. 2001), Pds1, con-
firming that spindle elongation could be equated with
anaphase in these cells (Supplementary Fig. 1). Remark-
ably, however, among the new mutant alleles of TOP2
that we isolated, G2/M delays were observed (Fig. 1A;
Supplementary Fig. 2). For consistency, each mutant was
assayed at 32°C (though most of the mutants tested were
inviable at higher temperatures). The length of G2/M in
one such mutant possessing a F977L substitution, top2-
B44, was studied in detail and found to be 46.2 ± 5.4 min
(n = 16 experiments) (Fig. 1A), >300% of the wild-type
G2/M period. In wild-type cells with large buds, the mi-
Yeast Topo II checkpoint
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totic spindle had invariably either elongated (anaphase)
or had recently disassembled (telophase) (Fig. 1B; top).
However, in top2-B44 mutants, the G2/M delay mani-
fested as cells with large buds and short G2 spindles (Fig.
1B, bottom).
The top2 strains that we generated contained CEN
plasmid-borne top2 alleles, covering a deletion of the en-
dogenous TOP2 gene (i.e., top2KAN pCEN-top2-B44).
Therefore, we sought to establish whether the presence
of the CEN plasmid had an effect on the length of G2/M.
In a strain containing the CEN plasmid harboring the
wild-type TOP2 gene (Fig. 1C), the G2/M period at 32°C
was consistent with that of cells not containing a CEN
plasmid. Moreover, strains in which the top2-B44 allele
was integrated at the endogenous locus (replacing the
wild-type TOP2 allele; top2top2-B44) or at the URA3
locus (in strains where endogenous TOP2 was deleted),
similar G2 delays were observed (Fig. 1C, bottom graph).
Therefore, the G2/M delay resulted from the top2-B44
mutation rather than the presence of the CEN plasmid.
We conclude that top2 mutations can result in a sub-
stantial lengthening of the G2/M cycle phase, consistent
with a checkpoint response being triggered as a result of
perturbed Topo II function.
G2/M delay in top2-B44 is DNA damage checkpoint
independent
In mammalian cells, whether Topo II checkpoints are
unique from DNA damage checkpoint controls is a mat-
ter of controversy. Drugs that inhibit Topo II without
inducing cleavable complex formation, and therefore
cannot induce DNA damage directly, nevertheless pro-
duce G2 and metaphase delays. But, it remains a possi-
bility that some dsDNA breaks are induced indirectly as
a consequence of Topo II inhibition, thus activating es-
tablished DNA damage checkpoint controls.
To unequivocally answer this question, we asked
whether top2-B44 mutants require DNA damage check-
point signaling to enforce the G2/M delay (Fig. 2). Using
the same cell cycle analysis as that described in Figure 1,
we observed that top2-B44 and top2-B44 rad53-1 cells,
the latter containing a checkpoint-null allele of the dam-
age checkpoint kinase Rad53/Chk2, behaved identically,
delaying in G2/M for ∼45 min (Fig. 2A). Moreover, Rad53
protein from top2-B44 cells did not undergo a robust
phosphorylation up-shift on SDS-PAGE gels that would
have been characteristic of DNA damage checkpoint ac-
tivation (although a minor fraction of Rad53 did appear
to have a reduced electrophoretic mobility; Fig. 2B).
Similarly, top2-B44 mec1-1 cells, null for Mec1-depen-
dent damage checkpoint function, delayed in G2/M be-
fore initiating mitosis; though in this case, our inability
to synchronize these cells efficiently in G1 made it dif-
ficult to determine the extent of the delay (Fig. 2C).
However, large budded cells with short G2 spindles were
frequently observed in this strain (data not shown).
Lastly, we measured DNA damage in top2-B44 cells by
counting Rad52 foci that form at sites of dsDNA break-
age (Lisby et al. 2003). Rad52 foci were present at similar
Figure 1. top2-B44 mutant cells delay in G2/M. Cell cycle analysis of wild-type versus top2 mutants at 32°C, released from mating
pheromone-induced G1 synchrony. Samples were processed for FACScan analysis of DNA content (not shown) and cytology (budding
and spindle morphology was scored). (A) Cell cycle progression after release from G1 in wild-type versus top2KAN pCEN-top2-B44
and top2-4. (B) Photomicrographs showing G2/M delay in top2KAN pCEN-top2-B44 cells; wild-type cells with large buds (top; photos
taken 70 min after release from G1) have elongated or disassembled spindles, while top2-B44 cells with large buds often contain short
G2 spindles (photos taken 80 or 90 min after release from G1). (C) Cell cycle progression after release from G1 in wild-type versus a
top2-null strain containing pCEN-TOP2(TRP1) (top two graphs) and in top2top2-B44 cells (bottom graph).
Andrews et al.
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low levels in wild-type and top2-B44 cells as they pro-
gressed through the cell cycle at 32°C, indicating that
the top2 mutant allele did not induce DNA damage as a
consequence of its functional impairment (Fig. 2D).
Some foci were expected to appear as cells progressed
through S phase, based on previous work (Lisby et al.
2003). Considering each of these experiments, we con-
clude that dsDNA breaks are not frequently induced in
top2-B44 cells and that the G2/M delay in these cells is
not due to DNA damage checkpoint activation.
G2/M delay in top2-B44 does not depend on Swe1
In budding yeast, there are two known mechanisms that
regulate onset of nuclear division. The first relies on
Swe1 kinase, which negatively regulates Cdc28, the bud-
ding yeast cyclin-dependent kinase (Cdk). Secondly, the
anaphase inhibitor, securin Pds1, can directly prevent
anaphase onset. We had noticed that Cdc28 became
modestly phosphorylated on Y19 in top2-B44 cells dur-
ing the extended G2/M period (Supplementary Fig. 3),
indicating a possible function of Swe1 in enforcing the
G2/M delay. However, the length of the G2/M phase in
top2-B44 swe1 cells was indistinguishable from that of
the top2-B44 single mutant (Fig. 3). Similarly, overex-
pression of Mih1, a phosphatase that counteracts Swe1-
dependent phosphorylation of Cdc28, did not shorten the
G2/M-phase period in top2-B44 cells (Fig. 3). We con-
clude that negative regulation of Cdc28, at least through
a known mechanism, is unlikely to produce the G2/M
delay in top2-B44 cells.
G2/M delay in top2-B44 depends on spindle
checkpoint components
We describe the cell cycle effect in top2-B44 cells as a
G2/M-phase delay because this cycle phase in budding
yeast is somewhat equivalent to metaphase in other eu-
karyotes (the mitotic spindle has assembled and the
chromosomes have become bioriented on the spindle). A
mammalian Topo II-dependent checkpoint has been ar-
gued to delay cells in metaphase—one report attributing
this drug-induced delay to the presence of DNA damage
(Mikhailov et al. 2002) and a conflicting study conclud-
ing that DNA damage is not the cause of the delay (Sk-
oufias et al. 2004). In both instances, however, there was
no evidence of spindle damage or a lack of chromosome
attachment to the mitotic spindle that might have trig-
gered the spindle-assembly checkpoint. Nevertheless,
the delay in mammalian cells was at least partly by-
passed in the absence of Mad2 (Mikhailov et al. 2002;
Skoufias et al. 2004). These studies suggest that a Topo
II-sensitive checkpoint might delay mammalian cells in
metaphase rather than G2. We therefore tested whether
the spindle checkpoint component Mad2 is required for
the G2/M delay in top2-B44 cells. As shown in Figure 3,
top2-B44 mad2 cells budded and performed spindle as-
sembly similar to wild-type cells. The G2/M delay seen
in top2-B44 was completely bypassed, however, by the
deletion of MAD2, indicating that Mad2 is a component
of the checkpoint system that induced a G2/M delay as
a consequence of limited Topo II function. Deletion of
Mad1, which forms a complex with Mad2, had a similar
effect (Fig. 3), as did other spindle checkpoint compo-
Figure 2. G2/M delay in top2-B44 is DNA damage checkpoint-independent. (A,C) Cell cycle analysis of double mutants of top2KAN
pCEN-top2-B44 combined with DNA damage checkpoint mutants, performed as described in Figure 1 after G1 synchrony. (A) Cell
cycle progression after release from G1 in top2-B44 rad53-1. (C) Cell cycle progression after release from G1 in top2-B44 mec1-1 sml1.
(B) Western blot showing Rad53 phosphorylation shift after hydroxyurea (HU) treatment, but no shift in wild-type or top2-B44 cells
progressing through the cell cycle at 32°C, released from mating pheromone-induced G1 synchrony. (D) Rad52 foci (a measure of the
presence of DNA breaks) in wild-type or top2-B44 cells progressing through the cell cycle at 32°C, released from mating pheromone-
induced G1 synchrony. Foci = cells with more than one fluorescent dot; focus = cells with one fluorescent dot.
Yeast Topo II checkpoint
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nents, Mad3 and Ipl1. The spindle checkpoint protein
Bub3 appeared to be partially required for the G2/M de-
lay, since in numerous experiments, top2-B44 bub3
cells always had a G2/M period that was extended com-
pared with wild-type cells, but that was shorter than
top2-B44 cells (Fig. 3). Unfortunately, we were unable to
determine whether Bub1 was required for the G2/M de-
lay, because top2-B44 bub1 cells were extremely sick
and could not be synchronized efficiently (data not
shown). Bub2, a component of the MEN pathway that
regulates exit from mitosis and responds to defects in
spindle orientation (Gardner and Burke 2000; Poddar et
al. 2004), was not required for the G2/M delay (data not
shown).
Having identified spindle checkpoint proteins needed
for the G2/M delay in top2-B44 cells, it is appropriate to
describe this as a checkpoint-dependent delay, based on
the classical genetic definition (Weinert and Hartwell
1988). It was equally important to determine whether
the checkpoint is biologically relevant; i.e., whether this
Topo II-dependent checkpoint enhances cell viability
under conditions of limited Topo II function. We there-
fore compared the temperature sensitivities of top2-B44,
top2-B44 mad2, and top2-B44 mad1 cells growing on
solid medium or after transient growth at high tempera-
ture in liquid medium (Supplementary Fig. 4A,B). In each
case, viability was reduced when MAD1 or MAD2 were
absent, indicating that the ability to execute the check-
point delay in G2/M is important for cell survival.
When cell cycle checkpoints are bypassed, either using
chemical inhibitors of checkpoint proteins or by genetic
deletion of an essential checkpoint component, informa-
tion about the function of the checkpoint system is often
revealed. However, the rapid loss of cell viability in top2-
B44 mad2 and top2-B44 mad1 mutants could have
stemmed from one of a number of cell cycle defects. If
cell death in these mutants was linked to inappropriate
anaphase onset in the presence of persistent DNA cat-
enations, then aberrant chromosome segregation would
be expected to occur, resulting in aneuploidy. To assay
for unequal chromosome segregation, we examined cells
prepared for FACScan analysis after a transient shift to
the nonpermissive temperature. In wild-type cells and
single mutants (top2-B44, mad1, or mad2), this treat-
ment did not result in cells containing <1C DNA con-
tent (Supplementary Fig. 4C). Strikingly, however, aneu-
ploid (<1C) double-mutant top2-B44 mad2 and
top2-B44 mad1 cells appeared after only 3 h at the
Figure 3. G2/M delay in top2-B44 depends on spindle checkpoint proteins, but not the Cdc28 kinase Swe1. Cell cycle analysis of
double mutants of top2top2-B44 combined with a swe1-null or spindle assembly checkpoint mutants, performed as described in
Figure 1 after G1 synchrony. In the case of the GAL1-MIH1 and top2top2-B44 GAL1-MIH1 strains, the cells were synchronized in
G1 in medium containing raffinose, then released into the cell cycle in the presence of galactose to induce overexpression of MIH1.
For each time point, at least 200 cells were scored. The averages of several counts are plotted and the error bars show standard
deviations. Derived from these data, approximate lengths of the G2/M period are listed for these stains in Supplementary Table 1.
Andrews et al.
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nonpermissive temperature (about two cell division
cycle times). Consistent with these data, DAPI staining
revealed that nuclear DNA of top2-B44 mad2 cells, but
not of top2-B44 cells, partitioned unequally during ana-
phase (Supplementary Fig. 4D). We conclude that per-
turbed Topo II function, in combination with a Topo II
checkpoint defect, results in aneuploidy and cell death.
Therefore, the Topo II checkpoint serves to protect from
genome damage.
G2/M checkpoint in top2-B44 is not enforced
by Pds1/securin
The only known target of the spindle checkpoint path-
way is the anaphase inhibitor Pds1/securin. Thus, we
expected that a lack of Pds1/securin would abolish the
ability of top2-B44 cells to delay in G2/M. However, af-
ter release from G1 synchrony of top2-B44 and top2-B44
pds1, both strains delayed in G2/M to the same extent
(Fig. 4). The length of the G2/M delay in these strains
was highly reproducible, indicating that the lack of Pds1
did not even partially bypass the G2/M delay (Supple-
mentary Fig. 5). Short and elongated spindles in all of the
strains compared in these experiments were of similar
lengths, suggesting that these parameters accurately rep-
resented G2/M phase and anaphase, respectively
(Supplementary Fig. 5). Consistent with these experi-
ments, G2/M delays were observed when top2-B44 cells
were compared with top2-B44 pds1-128, possessing a
checkpoint-null pds1 allele (Clarke et al. 1999; see
Supplementary Figs. 6, 7). Importantly, the G2/M delay
in top2-B44 pds1 and top2-B44 pds1-128 was not due to
the lack of Pds1/securin, since pds1-128 and pds1
single mutants progressed through G2/M with similar
timing to wild-type cells (Fig. 4; Supplementary Fig. 6).
Moreover, triple mutant strains, top2-B44 pds1 mad2
and top2-B44 pds1-128 mad2, progressed through
G2/M similar to wild type (Fig. 4; SupplementaryFig. 6),
indicating that the perturbed Topo II function combined
with the lack of Pds1 had not produced a deficiency that
made the correct timing of anaphase onset inherently
impossible.
A complication in the interpretation of the above
analyses is that Pds1 not only inhibits Esp1 to prevent
Figure 4. G2/M delay in top2-B44 is not en-
forced by Pds1/Securin. (A) Cell cycle analysis of
double and triple mutants of top2top2-B44
combined with pds1 or pds1mad2. Since the
pds1 cells are temperature-sensitive slightly
above 28°C, the G1 synchrony was performed at
26°C, then upon release from G1 the temperature
was shifted up to 28°C. (B) Cell cycle analysis of
top2top2-B44 pds1 in combination with
GAL1-ESP1-GFP-NLS (Jensen et al. 2001). Cells
were synchronized in medium containing raffi-
nose at 26°C, then upon release from G1 the tem-
perature was shifted up to 28°C and galactose
was added to induce expression of Esp1-GFP-
NLS. (Note that the cell cycle progresses slightly
slower in medium with raffinose/galactose as the
carbon source.) As previously described (Jensen
et al. 2001), accumulation of Esp1-GFP-NLS in
the nucleus occurred efficiently in the majority
of cells; photomicrographs show examples of
G2/M and anaphase cells with nuclear Esp1
(right) and cells not expressing Esp1-GFP (left) for
comparison.
Yeast Topo II checkpoint
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anaphase onset, but also aids in the nuclear import of
Esp1, allowing Esp1 to access its targets. The possibility
that G2/M delay in top2-B44 pds1 cells results from
insufficient nuclear Esp1 must therefore be excluded. To
address this concern, we compared the length of the
G2/M period in top2-B44 pds1 cells with the same cells
overexpressing Esp1 that possessed an engineered
nuclear localization signal (GAL1-ESP1-NLS) and had
been previously shown to efficiently enter the nucleus in
the absence of Pds1 (Jensen et al. 2001). Upon release
from G1 synchrony, we were able to confirm efficient
localization of Esp1-NLS to the nucleus, since the pro-
tein was also fused to GFP (Fig. 4). As a functional test
for Esp1-NLS, we confirmed previous studies that dem-
onstrated partial rescue of pds1 temperature sensitivity
(Jensen et al. 2001; data not shown). Importantly, the
duration of G2/M phase was indistinguishable whether
or not Esp1-NLS was overexpressed (Fig. 4) in top2-B44
pds1 cells.
Together, these experiments demonstrate that the
checkpoint enforced by spindle checkpoint proteins, in
response to perturbed Topo II function, cannot act via
Pds1/securin. The budding yeast Topo II checkpoint
must therefore be distinct from the spindle-assembly
checkpoint, at least with respect to its target.
G2/M delay in top2-B44 mutants depends
on the anaphase-promoting complex (APC)
That top2-B44 elicits a Pds1-independent pre-anaphase
delay brings two important issues into question: first,
whether inhibition of proteolysis by the APC is the
mechanism of action of the Topo II checkpoint, and sec-
ond, whether the delayed anaphase observed in top2-B44
cells indeed reflects anaphase onset in its normal cell
cycle context. We began to address these questions by
asking whether APC is inhibited during G2/M phase in
top2-B44 cells. In this case, even though Pds1 is not re-
quired for the G2/M delay, we would expect subsequent
events such as Pds1 degradation and nucleolar Cdc14
release to be delayed. First, we examined the kinetics of
Cdc14 release from the nucleolus in wild-type and top2-
B44 cells (Supplementary Fig. 8). Consistent with previ-
ous work, partial Cdc14 release occurred coincident with
the onset of spindle elongation in wild-type cells. In
top2-B44 cells, partial Cdc14 release was substantially
delayed, and in most cells, it did not occur until spindle
elongation, although some G2/M top2-B44 cells were
seen in which Cdc14 had become at least partially delo-
calized (Supplementary Fig. 8). Overall, however, these
data indicated that the G2/M delay was accompanied by
retention of Cdc14 in the nucleolus, and that Cdc14 re-
lease was coordinated with spindle elongation (though
perhaps less efficiently than in the context of an unper-
turbed cell cycle).
We next examined Pds1 protein levels after release
from G1 synchrony using an epitope-tagged (3xHA) ver-
sion or Pds1. In wild-type and top2-B44 cells, some Pds1
was degraded 50–60 min after release from G1 synchrony
(Fig. 5). Anaphase proceeded shortly thereafter in wild-
type cells and most of the remaining Pds1 was, as ex-
pected, degraded consistent with the timing of mitotic
exit (data not shown). However, in top2-B44 cells, the
remaining Pds1 protein (at 50 min) stayed at a constant
level until the time of anaphase, 110–120 min after re-
lease from G1. This indicated that with respect to its
target Pds1, the APC was partially inhibited during
G2/M in top2-B44 cells, and made it important to deter-
mine whether the APC was essential for spindle elonga-
tion in top2-B44 cells. To ask whether spindle elonga-
tion was completely dependent on the APC, we analyzed
top2-B44 apc2-4 cells after release from G1 synchrony at
the nonpermissive temperature for the apc2-4 mutation
(Kramer et al. 1998). Spindle assembly in this strain oc-
curred at a time similar to that in top2-B44 cells, but
then these cells became blocked in G2/M phase with
short spindles for at least 30 min after spindle elongation
ought to have occurred (up to 150 min after G1 release;
Fig. 5). This requirement for APC for spindle elongation
in top2-B44 cells is consistent with the idea that the
changes in microtubule dynamics leading to spindle
elongation are indeed associated with anaphase onset.
This is an important point to clarify since spindle elon-
gation is not always APC-dependent and is not always
indicative of anaphase onset (Clarke et al. 2003;
Krishnan et al. 2004). We further evaluated this latter
issue by examining loss of cohesion and segregation of a
chromosome arm locus (LYS4) in wild-type and top2-B44
Figure 5. Spindle elongation in top2-B44 cells depends on the
APC. (A) Timing of Pds1-3xHA degradation in top2-B44 cells.
Cells were released from G1 synchrony as described in Figure 1
and samples were taken for scoring budding and spindle mor-
phologies, as well as for preparing whole-cell protein extracts for
Western blots. Pds1 was detected using an anti-HA antibody,
and as a loading control, Cdc28 was detected using the PSTAIRE
antibody. Percent anaphase cells at each time point is indicated
beneath the Western blots. (B) Cell cycle analysis of top2top2-
B44 in combination with the apc2-4 mutation. Cells were syn-
chronized in G1 at 26°C, then upon release from G1 the tem-
perature was shifted up to 32°C, the nonpermissive temperature
for the apc2-4 mutation. Budding and spindle morphologies
were scored as described in Figure 1.
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cells. The timing of LYS4 segregation in top2-B44 cells
was consistent with execution of a normal anaphase, af-
ter the G2/M delay (Supplementary Fig. 9). Based on all
of these data—delayed Pds1 degradation, delayed Cdc14
release from the nucleolus, delayed LYS4 segregation,
and the dependence of spindle elongation on the APC—
we conclude that top2-B44 cells undergo an essentially
normal anaphase after the G2/M-phase delay.
The simplest interpretation of these findings is that
the G2/M delay in top2-B44 cells is enforced by inhibi-
tion of the APC by spindle assembly checkpoint pro-
teins. We sought to determine whether Mad2-dependent
inhibition of Cdc20 could account for APC inhibition
during the G2/M delay in top2-B44 cells. We found that
expression of a dominant allele of CDC20 (cdc20–50)
(Schott and Hoyt 1998) that can activate the APC but is
resistant to inactivation by Mad2 resulted in a partial
bypass of the G2/M delay in top2-B44 cells (Supplemen-
tary Fig. 10). These data indicate that inhibition of Cdc20
by Mad2 at least partly accounts for inhibition of ana-
phase in top2-B44 cells. However, since only partial by-
pass was achieved, we cannot rule out the possibility
that the spindle checkpoint acts through an additional
mechanism to achieve APC inhibition. Nevertheless, all
of these data suggest that APC inhibition leads to stabi-
lization of an unknown anaphase inhibitor, other than
Pds1, to enforce the G2/M delay.
Chromosomes biorient properly in top2-B44 cells
That Pds1/securin was not required for the G2/M delay
in top2-B44 cells led us to question whether or not a
conventional spindle checkpoint mechanism was trig-
gered. The spindle checkpoint monitors kinetochore–
microtubule interactions, and thus the functional integ-
rity of the spindle apparatus and kinetochores. When
chromosomes are correctly bioriented, the spindle
checkpoint is satisfied and Mad2-dependent inhibition
of APC is reversed.
To ask whether top2-B44 cells are defective in satisfy-
ing the spindle checkpoint, we first compared the kinet-
ics of chromosome biorientation in mutant and wild-
type cells. In budding yeast, centromere DNA replica-
tion is completed well before anaphase (McCarroll and
Fangman 1988); kinetochores can assemble and chromo-
somes are captured even while DNA replication is on-
going (Winey et al. 1995). Correct biorientation results in
precocious centromere separation in budding yeast, re-
sulting from the accurate attachment of a single micro-
tubule from each spindle pole to each sister kinetochore
in a bipolar arrangement, producing tension between the
centromere regions (Fig. 6A; Goshima and Yanagida
2000). Analysis of the timing of precocious separation
therefore measures kinetochore and spindle function as
well as biorientation and tension. After release from G1
synchrony, wild-type and top2-B44 cells budded and ini-
tiated DNA synthesis after ∼30 min (Fig. 6B), the first
cells reaching G2/M after ∼40–50 min in each case. Biori-
entation, as measured by precocious separation of a locus
1.2 kb away from CEN4, also occurred with similar tim-
ing in the two strains. While anaphase, based on the
segregation of this locus, occurred ∼12 min after preco-
cious separation in wild-type cells, it was not initiated in
the top2-B44 cells until ∼35 min after precocious sepa-
ration, consistent with the G2/M delay described above,
based on spindle morphology. Thus, chromosomes seem
to become bioriented with the correct timing in top2-
B44 cells, and the spindle assembly checkpoint ought to
have been satisfied. It is noteworthy, however, that this
assay would be insensitive to more subtle defects in
chromosome attachment.
top2-B44 cells do not delay after release
from nocodazole-induced arrest
The spindle-assembly checkpoint monitors chromo-
some biorientation, and in response, controls the meta-
phase-to-anaphase transition. But the top2-B44 mutation
delays cells prior to anaphase irrespective of correct
chromosome biorientation. An inherent feature of the
budding yeast cell cycle is that G2 phase and metaphase
are not distinguishable cytologically. Since the spindle
checkpoint ought to be satisfied in top2-B44 cells, we
postulated that the cell cycle delay might in fact be a G2
delay triggered by reduced Topo II function. Alterna-
tively, G2 and metaphase may indeed be indistinguish-
able in budding yeast, and the pre-anaphase delay seen in
top2-B44 cells might be induced by slow decatenation
rather than a kinetochore–spindle attachment defect. In
either case, we would predict that top2-B44 cells ought
to initiate anaphase spindle elongation with the same
timing as wild-type cells when released from a noco-
dazole arrest. Our logic was to assume that nocodazole
synchrony would either allow extra time for adequate
resolution of the catenations or would allow the cells to
progress beyond G2, after which the checkpoint would
cease to function. To test these ideas, we arrested wild-
type and top2-B44 cells in G1, with mating pheromone
then released into the cell cycle at 32°C in the presence
of nocodazole. Following release from G1, the cells reach
G2/M after ∼50–60 min (Figs. 1–5). We therefore released
from the nocodazole synchrony after a further 60 min,
making the assumption that residual catenations would
be resolved within this time frame and/or that the cells
would progress beyond G2 phase. After removal of the
nocodazole, wild-type and the top2-B44 cells assembled
short spindles with similar timing. Anaphase was also
initiated with similar kinetics in both strains, indicating
that in agreement with the precocious CEN4 separation
assay, chromosomes became attached to the spindle in a
bipolar arrangement, and the spindle checkpoint was sat-
isfied equally well in wild-type and top2-B44 cells (Fig.
6C).
We conclude that the likely cause of the cell cycle
delay in top2-B44 cells is not a defect in spindle or ki-
netochore function, nor a defect in microtubule–kineto-
chore attachment, but rather a lack of Topo II function
related to its decatenatory activity (Fig. 6D). This may
help to explain why this checkpoint has a target other
than Pds1. The extra time spent prior to anaphase (in the
Yeast Topo II checkpoint
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presence of nocodazole) might have allowed the cells to
progress beyond the cell cycle stage in which the check-
point was operational (presumably G2) or could have
simply allowed extra time for decatenation to occur,
thus neutralizing the cause of checkpoint activation.
Discussion
The failure of Topo II checkpoint controls is likely to
result in genome damage and genome instability
(Trigueros and Roca 2001). Moreover, Topo II-dependent
checkpoint defects were found in a subset of human can-
cers (Nakagawa et al. 2004), raising the possibility that
such checkpoint defects could contribute to cancer eti-
ology. An important study found that in some instances,
Topo II-dependent checkpoint arrest led to mitotic cell
death. Checkpoint-incompetent cells that were chal-
lenged with a chemotherapeutic Topo II poison were re-
sistant to mitotic cell death, indicating that somatic mu-
tations that inactivate Topo II checkpoints in tumor
cells might cause resistance to chemotherapeutics that
target Topo II (Vogel et al. 2005).
We report here the first description of a Topo II-depen-
dent checkpoint in a genetically amenable eukaryote,
budding yeast. This checkpoint apparently escaped pre-
vious detection because the commonly used top2-4 tem-
perature-sensitive allele of TOP2 does not induce acti-
vation of this checkpoint pathway. We isolated new top2
alleles, most of which activate a G2/M checkpoint con-
trol, and we have characterized one such allele in detail
(top2-B44). We provide evidence that DNA damage
checkpoint components are not needed to enforce this
checkpoint system that is triggered by perturbed Topo II
function, and define in genetic terms several compo-
nents of this pathway. Surprisingly, the yeast anaphase
inhibitor Pds1/securin is not the checkpoint target. Nev-
Figure 6. Chromosomes biorient properly in top2-B44 cells. (A) Schematic representation (cartoons) and photomicrographs describing
a chromosome biorientation assay in budding yeast. (Left) A locus at CEN4 is tagged with a fluorescent signal (see Materials and
Methods) yielding a single fluorescent dot in small budded cells. (Middle) Two closely apposed fluorescent spots are seen once the
CEN4 locus has been replicated and has undergone the typical precocious separation (Goshima and Yanagida 2000) seen when the
chromosome becomes bioriented, and is under spindle tension. (Right) During anaphase, the spots are segregated to the mother and
daughter cells. (B) Cell cycle analysis of wild-type and top2-B44 mutants after release from G1 synchrony. (Bottom) Cell morphologies
were scored as depicted in A, and samples were processed for FACScan analysis of DNA content (time points are shown at the side
of each histogram plot and the vertical lines indicate approximate position of 1C and 2C DNA contents). (C) Cell cycle analysis of
wild-type versus top2-B44 mutants at 32°C. Cells were released from mating pheromone-induced G1 synchrony into medium con-
taining nocodazole, then released from the nocodazole after 120 min. Samples were processed for cytology and spindle morphology was
scored. (D) Model showing the proposed relationship between the Topo II checkpoint and the spindle assembly checkpoint in yeast.
We suggest that the Topo II checkpoint is activated until decatenation reactions have been performed adequately to allow a successful
mitosis. In this case, anaphase is inhibited independently of Pds1/securin.
Andrews et al.
1170 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on May 13, 2014 - Published by genesdev.cshlp.orgDownloaded from 
ertheless, a lack of this novel cell cycle checkpoint under
conditions of perturbed Topo II function results in aneu-
ploidy and cell death.
Previous work in mammalian cells relied on the use of
inhibitors to study functions of Topo II in vivo. Com-
monly used drugs such as etoposide bind to Topo II ei-
ther before or after passage of the T-strand, to form what
is known as a “cleavable complex” (Zwelling et al. 1991).
The topoisomerase II-mediated religation reaction, the
last step of decatenation, is prevented and ultimately
dsDNA breaks result. DNA damage affects cell cycle
progression by inactivating p34cdc2–cyclin B1 complexes
(Lock and Ross 1990), the kinase activity responsible for
inducing entry into mitosis. Even the more recently used
Topo II poisons that apparently do not cause gross chro-
mosome damage, the bisdioxopiperazines (e.g., ICRF-
193), have been reported to induce DNA breaks indi-
rectly as a consequence of Topo II dysfunction (Mikhai-
lov et al. 2002). Thus, it has been difficult to make firm
conclusions as to whether insufficient decatenation per
se activates a checkpoint control independent of DNA
damage that could be a consequence of persistent cat-
enation. Using a yeast genetic system, however, we re-
solved this issue by demonstrating checkpoint activa-
tion in top2-B44 mutants that does not require key DNA
damage checkpoint components such as Rad53, Mec1,
and Pds1 (although we note that there are other DNA
damage-responsive checkpoint kinases in yeast cells).
We cannot rule out the possibility that DNA damage
checkpoint controls are stimulated to some degree in
top2-B44 cells because a minor population of (presum-
ably) phosphorylated Rad53 was detectable on Western
blots (see Fig. 2). However, we were unable to detect an
increase in Rad52-containing nuclear foci in top2-B44
cells, indicating that double-stranded breaks were not
more frequent than in wild-type cells.
While conflicting studies disagree over whether Topo
II poisons such as ICRF-193 cause DNA damage, they
similarly attest that the induced metaphase delay re-
quires Mad2, an inhibitor of APC/CCdc20. In mammals,
Mad2 and Bub1 locate to kinetochores when the spindle
checkpoint is activated (for review, see Nasmyth 2002),
but photon counting studies have shown that this does
not occur when the Topo II-dependent checkpoint is ac-
tivated in metaphase (Skoufias et al. 2004). Spindle ten-
sion in metaphase, measured by the interkinetochore
distance after Topo II inhibition, was indistinguishable
from control metaphase cells (Skoufias et al. 2004). Con-
versely, defective cohesion that leads to chromosome
misorientation and spindle checkpoint activation can be
corrected by residual catenations maintained by Topo II
inhibition (Vagnarelli et al. 2004). This correction not
only restored sister association, but presumably also
biorientation and tension, because the spindle check-
point became silenced. Together, these studies indicate
that inhibition of Topo II during mammalian mitosis
does not activate the spindle checkpoint. Despite this,
genetic studies using yeast have revealed that the sum-
oylation state of Top2 has important consequences
within centric chromatin perhaps related to kinetochore
structure/function (Bachant et al. 2002). This suggests
that altered Top2 sumoylation might activate the
spindle checkpoint due to the functional impairment of
kinetochores or centromeric chromatin. Nonsumoylat-
able top2 mutants (top2-SNM) progress through G2/M
with wild-type cell cycle kinetics (J. Bachant, pers.
comm.), arguing that a lack of Top2 sumoylation does
not result in checkpoint activation. In addition, none of
the top2 mutant alleles that we found to delay in G2/M
had mutations in any of the Top2 lysine residues that
become sumoylated (Supplementary Fig. 2). We have
not, however, excluded the possibility that other sum-
oylation defects (such as increased Top2 sumoylation)
might be involved in activating the G2/M checkpoint in
top2-B44 cells.
Here we have used genetic analyses in yeast to show
that top2 mutants delay G2/M progression without a
defect in chromosome biorientation, indicating that
spindle and kinetochore functions are not perturbed.
Taken together, these observations indicate that Topo II
inhibition cannot result in a defect that triggers the
spindle checkpoint. Our data, however, show unequivo-
cally that yeast spindle checkpoint components are re-
quired to enforce the Topo II checkpoint. Thus, the Topo
II checkpoint is distinct from the spindle checkpoint, but
utilizes these key anaphase regulators.
In ICRF-193-induced mammalian mitotic arrest, Mad2
is associated with Cdc20 and Pds1/securin is stable (Sk-
oufias et al. 2004). This observation suggested that
Mad2-dependent APC inactivation prevents Pds1/se-
curin degradation, thereby inhibiting anaphase onset.
However, we find that a lack of Pds1 does not bypass the
G2/M delay in yeast top2-B44 cells. Thus, we have dem-
onstrated that Pds1/securin, the only known target
downstream of the Mad1–Mad2 pathway in yeast is dis-
pensable for the Topo II checkpoint response. These data
indicate that a novel anaphase restraint mechanism is
invoked in top2-B44 cells.
The nature of the cellular process monitored by Topo
II-dependent checkpoints has not been determined. This
is because it has been difficult to distinguish Topo II
activity per se from physical aspects of chromosome
structure that are formed as a consequence of Topo II
activity. Here we have ruled out the possibility that one
indirect consequence of perturbed Topo II, DNA breaks,
is monitored by the checkpoint. A question that remains
is whether decreased Topo II activity itself or persistent
DNA catenation are monitored by the checkpoint. We
have found that mutant top2 alleles differ in their ability
to activate the checkpoint (Fig. 1; Supplementary Fig. 2).
Thus, by comparing the defects that these alleles pos-
sess, and with a more detailed understanding of the Topo
II catalytic cycle, we may eventually be able to gain in-
sight into this important question.
In summary, we have genetically defined a Topo II
checkpoint in yeast and provided evidence that it is
needed for cell viability and the maintenance of eu-
ploidy. The checkpoint mechanism relies on spindle
checkpoint components, but is not activated by spindle
damage or a lack of proper chromosome biorientation.
Yeast Topo II checkpoint
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Regulation of anaphase onset in budding yeast is thought
to depend on the Esp1/separase inhibitor Pds1/securin.
But, since the Topo II checkpoint has a novel target, we
speculate that anaphase onset might be controlled by an
alternative mechanism (Fig. 6D).
Materials and methods
Yeast strain and plasmid construction
All strains are derived from BF264-15 15DU: MATa ura3ns
ade1 his2 leu2-3,112 trp1-1a (Richardson et al. 1989). The TOP2
gene and its promoter were cloned by colony PCR and the PCR
product was inserted into YCp50(URA3) and pRS414(TRP1).
The TOP2 ORF was deleted as described (Wach et al. 1994).
Temperature-sensitive top2 alleles were produced by random
PCR-based mutagenesis combined with the plasmid shuffle
method as previously described (Jensen et al. 2001).
Yeast strain genotypes
For yeast strain genotypes, see Supplemental material.
Yeast cell cycle experiments
Cells were grown to OD 2.0–4.0 overnight in synthetic medium
containing additional adenine. For synchrony, cells were di-
luted to OD 0.15 in rich medium with  factor (concentrations
varying from 1:1000 to 1:5000 of a 1 mg/mL stock). After 2–3 h,
cells were monitored microscopically and experiments were
typically performed only if G1 synchrony of 85%–100% was
reached.  Factor was washed off with water and cells were
released under experimental conditions. Nocodazole was used
at 0.15 µg/mL. At each time point and for each strain, at least
200 cells were scored for cytology and samples were taken for
FACScan analysis as described previously (Clarke et al. 2001;
Haase and Reed 2002) using Sytox green DNA stain (Molecular
Probes, Inc.). The G2/M cell cycle interval was measured for
wild-type cells and top2-B44 mutants by selecting time-course
experiments that adhered to the following criteria: (1) the per-
centage of cells with elongated spindles at a single time point
reached at least 35%, and (2) the kinetics of spindle formation
and spindle elongation were approximately parallel. Then, we
measured the time interval between spindle formation and
elongation at the 35% elongated spindles mark. Standard devia-
tions of the mean of at least eight experimental determinations
were calculated.
Microscopy
Spindle morphologies were visualized using TUB1-GFP
(Straight et al. 1997) and centromeres and the LYS4 locus were
detected using the lacO/lacR-GFP system (Straight et al. 1996).
Fluorescence and DIC microscopy with Plan Apo 63×/1.4 and
Alpha Plan Fluar 100×/1.45 objectives and a Zeiss Axio Plan II
microscope were used for scoring and capturing images of live
cells with a Zeiss Axiocam camera and Axiovision software.
Biochemistry
Protein extracts were prepared using the glass bead method in
NP40 buffer (50 mM Tris-HCl at pH 7.5, 250 mM NaCl, 0.1%
NP40, 10 mM sodium pyrophosphate, 5 mM EDTA, 0.1 mM
orthovanadate, 1 mM PMSF, 2 µg/mL aprotinin, 2 µg/mL pep-
statin, and 1 µg/mL leupeptin) and Western blots were per-
formed as previously described (Jensen et al. 2001) using the
following antibodies: 1:10,000 dilution of anti-HA (Santa Cruz)
and a 1:10,000 dilution of anti-PSTAIRE. Secondary antibody,
HRP-conjugated goat anti-mouse (Pierce) was used at 1:5000
and Western Lightning Chemiluminescence Reagent Plus (Per-
kin Elmer Life Sciences) was used as per the manufacturer’s
instructions.
Acknowledgments
We thank R. Rothstein for the Rad52-YFP strain, C. Holm for
the top2-4 strain, C. Wittenberg for the RAD53-3xHA con-
struct, A. Hoyt for the cdc20-50 mutant, D. Lew for the swe1
and GAL1-MIH1 strains, S. Biggins for the ipl-321 strain, S.
Jensen for the GAL1-ESP1-NLS strain, L. Johnson for the apc2-4
strain, R. Li and K. Lee for the Cdc14-GFP strain, and J. Bachant
for the LYS4-LacO strain. This work was funded by NIH grant
CA099033 (D.J.C.).
References
Adachi, Y., Luke, M., and Laemmli, U.K. 1991. Chromosome
assembly in vitro: Topoisomerase II is required for conden-
sation. Cell 64: 137–148.
Adachi, N., Iiizumi, S., So, S., and Koyama, H. 2004. Genetic
evidence for involvement of two distinct nonhomologous
end-joining pathways in repair of topoisomerase II-mediated
DNA damage. Biochem. Biophys. Res. Commun. 318: 856–
861.
Bachant, J., Alcasabas, A., Blat, Y., Kleckner, N., and Elledge, S.J.
2002. The SUMO-1 isopeptidase Smt4 is linked to centro-
meric cohesion through SUMO-1 modification of DNA to-
poisomerase II. Mol. Cell 9: 1169–1182.
Charron, M. and Hancock, R. 1990. DNA topoisomerase II is
required for formation of mitotic chromosomes in Chinese
hamster ovary cells: Studies using the inhibitor 4-demethy-
lepipodophyllotoxin 9-(4,6-O-thenylidene--D-glucopyrano-
side). Biochemistry 29: 9531–9537.
Clarke, D.J. and Giménez-Abián, J.F. 2000. Checkpoints con-
trolling mitosis. Bioessays 22: 351–363.
Clarke, D.J., Johnson, R.T., and Downes, C.S. 1993. Topoisom-
erase II inhibition prevents anaphase chromatid segregation
in mammalian cells independently of the generation of DNA
strand breaks. J. Cell Sci. 105: 563–569.
Clarke, D.J., Segal, M., Mondesert, G., and Reed, S.I. 1999. The
Pds1 anaphase inhibitor and Mec1 kinase define distinct
checkpoints coupling S phase with mitosis in budding yeast.
Curr. Biol. 9: 365–368.
Clarke, D.J., Segal, M., Jensen, S., and Reed, S.I. 2001. Mec1p
regulates Pds1p levels in S phase: Complex coordination of
DNA replication and mitosis. Nat. Cell Biol. 3: 619–627.
Clarke, D.J., Segal, M., Andrews, C.A., Rudyak, S.G., Jensen, S.,
Smith, K., and Reed, S.I. 2003. S-phase checkpoint controls
mitosis via an APC-independent Cdc20p function. Nat. Cell
Biol. 21: 21.
Cook, P.R. 1991. The nucleoskeleton and the topology of repli-
cation. Cell 66: 627–635.
Creighton, A.M. and Birnie, G.D. 1969. The effect of bisdioxo-
piperazines on the synthesis of deoxyribonucleic acid, ribo-
nucleic acid and protein in growing mouse-embryo fibro-
blasts. Biochem. J. 114: 58P.
Deming, P.B., Cistulli, C.A., Zhao, H., Graves, P.R., Piwnica-
Worms, H., Paules, R.S., Downes, C.S., and Kaufmann, W.K.
2001. The human decatenation checkpoint. Proc. Natl.
Andrews et al.
1172 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on May 13, 2014 - Published by genesdev.cshlp.orgDownloaded from 
Acad. Sci. 98: 12044–12049.
DiNardo, S., Voelkel, K., and Sternglanz, R. 1984. DNA topoi-
somerase II mutant of Saccharomyces cerevisiae: Topoisom-
erase II is required for segregation of daughter molecules at
the termination of DNA replication. Proc. Natl. Acad. Sci.
81: 2616–2620.
Dominguez, I., Pastor, N., Mateos, S., and Cortes, F. 2001. Test-
ing the SCE mechanism with non-poisoning topoisomerase
II inhibitors. Mutat. Res. 497: 71–79.
Downes, C.S., Clarke, D.J., Mullinger, A.M., Giménez-Abián,
J.F., Creighton, A.M., and Johnson, R.T. 1994. A topoisom-
erase II-dependent G2 cycle checkpoint in mammalian cells.
Nature 372: 467–470.
Earnshaw, W.C., Halligan, B., Cooke, C.A., Heck, M.M., and
Liu, L.F. 1985. Topoisomerase II is a structural component of
mitotic chromosome scaffolds. J. Cell Biol. 100: 1706–1715.
Gardner, R.D. and Burke, D.J. 2000. The spindle checkpoint:
Two transitions, two pathways. Trends Cell Biol. 10: 154–
158.
Giménez-Abián, J.F. and Clarke, D.J. 2003. Replication-coupled
topoisomerase II templates the mitotic chromosome scaf-
fold? Cell Cycle 2: 230–232.
Giménez-Abián, J.F., Clarke, D.J., Mullinger, A.M., Downes,
C.S., and Johnson, R.T. 1995. A postprophase topoisomerase
II-dependent chromatid core separation step in the forma-
tion of metaphase chromosomes. J. Cell Biol. 131: 7–17.
Giménez-Abián, J.F., Clarke, D.J., Devlin, J., Giménez-Abián,
M., De la Torre, C., Johnson, R.T., Mullinger, A.M., and
Downes, C.S. 2000. Premitotic chromosome individualiza-
tion in mammalian cells depends on topoisomerase II activ-
ity. Chromosoma 109: 235–244.
Gimenez-Abian, J.F., Weingartner, M., Binarova, P., Clarke,
D.J., Anthony, R.G., Calderini, O., Heberle-Bors, E., Moreno
Diaz de la Espina, S., Bogre, L., and De la Torre, C. 2002. A
topoisomerase II-dependent checkpoint in G2-phase plant
cells can be bypassed by ectopic expression of mitotic cyclin
B2. Cell Cycle 1: 187–192.
Goshima, G. and Yanagida, M. 2000. Establishing biorientation
occurs with precocious separation of the sister kinetochores,
but not the arms, in the early spindle of budding yeast. Cell
100: 619–633.
Haase, S.B. and Reed, S.I. 2002. Improved flow cytometric analy-
sis of the budding yeast cell cycle. Cell Cycle 1: 132–136.
Hajji, N., Pastor, N., Mateos, S., Dominguez, I., and Cortes, F.
2003. DNA strand breaks induced by the anti-topoisomerase
II bis-dioxopiperazine ICRF-193. Mutat. Res. 530: 35–46.
Hirano, T. and Mitchison, T.J. 1991. Cell cycle control of
higher-order chromatin assembly around naked DNA in
vitro. J. Cell Biol. 115: 1479–1489.
Holm, C., Goto, T., Wang, J.C., and Botstein, D. 1985. DNA
topoisomerase II is required at the time of mitosis in yeast.
Cell 41: 553–563.
Jensen, S., Segal, M., Clarke, D.J., and Reed, S.I. 2001. A novel
role of the budding yeast separin Esp1 in anaphase spindle
elongation: Evidence that proper spindle association of Esp1
is regulated by Pds1. J. Cell Biol. 152: 27–40.
Kalwinsky, D.K., Look, A.T., Ducore, J., and Fridland, A. 1983.
Effects of the epipodophyllotoxin VP-16-213 on cell cycle
traverse, DNA synthesis, and DNA strand size in cultures of
human leukemic lymphoblasts. Cancer Res. 43: 1592–1597.
Kramer, K.M., Fesquet, D., Johnson, A.L., and Johnston, L.H.
1998. Budding yeast RSI1/APC2, a novel gene necessary for
initiation of anaphase, encodes an APC subunit. EMBO J. 17:
498–506.
Krishnan, V., Nirantar, S., Crasta, K., Cheng, A.Y., and Surana,
U. 2004. DNA replication checkpoint prevents precocious
chromosome segregation by regulating spindle behavior.
Mol. Cell 16: 687–700.
Lisby, M., Antunez de Mayolo, A., Mortensen, U.H., and Roth-
stein, R. 2003. Cell cycle-regulated centers of DNA double-
strand break repair. Cell Cycle 2: 479–483.
Lock, R.B. and Ross, W.E. 1990. Inhibition of p34cdc2 kinase
activity by etoposide or irradiation as a mechanism of G2
arrest in Chinese hamster ovary cells. Cancer Res. 50: 3761–
3766.
McCarroll, R.M. and Fangman, W.L. 1988. Time of replication
of yeast centromeres and telomeres. Cell 54: 505–513.
Mikhailov, A., Cole, R.W., and Rieder, C.L. 2002. DNA damage
during mitosis in human cells delays the metaphase/ana-
phase transition via the spindle-assembly checkpoint. Curr.
Biol. 12: 1797–1806.
Mikhailov, A., Shinohara, M., and Rieder, C.L. 2004. Topoisom-
erase II and histone deacetylase inhibitors delay the G2/M
transition by triggering the p38 MAPK checkpoint pathway.
J. Cell Biol. 166: 517–526.
Munoz, P., Baus, F., and Piette, J. 2001. Ku antigen is required to
relieve G2 arrest caused by inhibition of DNA topoisomer-
ase II activity by the bisdioxopiperazine ICRF-193. Onco-
gene 20: 1990–1999.
Nakagawa, T., Hayashita, Y., Maeno, K., Masuda, A., Sugito, N.,
Osada, H., Yanagisawa, K., Ebi, H., Shimokata, K., and Ta-
kahashi, T. 2004. Identification of decatenation G2 check-
point impairment independently of DNA damage G2 check-
point in human lung cancer cell lines. Cancer Res. 64: 4826–
4832.
Nasmyth, K. 2002. Segregating sister genomes: The molecular
biology of chromosome separation. Science 297: 559–565.
Newport, J. 1987. Nuclear reconstitution in vitro: Stages of as-
sembly around protein-free DNA. Cell 48: 205–217.
Poddar, A., Daniel, J.A., Daum, J.R., and Burke, D.J. 2004. Dif-
ferential kinetochore requirements for establishment and
maintenance of the spindle checkpoint are dependent on the
mechanism of checkpoint activation in Saccharomyces cer-
evisiae. Cell Cycle 3: 197–204.
Richardson, H.E., Wittenberg, C., Cross, F.R., and Reed, S.I.
1989. An essential G1 function for cyclin-like proteins in
yeast. Cell 59: 1127–1133.
Schott, E.J. and Hoyt, M.A. 1998. Dominant alleles of Saccha-
romyces cerevisiae CDC20 reveal its role in promoting ana-
phase. Genetics 148: 599–610.
Shamu, C.E. and Murray, A.W. 1992. Sister chromatid separa-
tion in frog egg extracts requires DNA topoisomerase II ac-
tivity during anaphase. J. Cell Biol. 117: 921–934.
Skoufias, D.A., Lacroix, F.B., Andreassen, P.R., Wilson, L., and
Margolis, R.L. 2004. Inhibition of DNA decatenation, but
not DNA damage, arrests cells at metaphase. Mol. Cell 15:
977–990.
Straight, A.F., Belmont, A.S., Robinett, C.C., and Murray, A.W.
1996. GFP tagging of budding yeast chromosomes reveals
that protein–protein interactions can mediate sister chroma-
tid cohesion. Curr. Biol. 6: 1599–1608.
Straight, A.F., Marshall, W.F., Sedat, J.W., and Murray, A.W.
1997. Mitosis in living budding yeast: Anaphase A but no
metaphase plate. Science 277: 574–578.
Sundin, O. and Varshavsky, A. 1981. Arrest of segregation leads
to accumulation of highly intertwined catenated dimers:
Dissection of the final stages of SV40 DNA replication. Cell
25: 659–669.
Tanabe, K., Ikegami, Y., Ishida, R., and Andoh, T. 1991. Inhibi-
tion of topoisomerase II by antitumor agents bis(2,6- dioxo-
Yeast Topo II checkpoint
GENES & DEVELOPMENT 1173
 Cold Spring Harbor Laboratory Press on May 13, 2014 - Published by genesdev.cshlp.orgDownloaded from 
piperazine) derivatives. Cancer Res. 51: 4903–4908.
Trigueros, S. and Roca, J. 2001. Circular minichromosomes be-
come highly recombinogenic in topoisomerase-deficient
yeast cells. J. Biol. Chem. 276: 2243–2248.
Uemura, T. and Yanagida, M. 1984. Isolation of type I and II
DNA topoisomerase mutants from fission yeast: Single and
double mutants show different phenotypes in cell growth
and chromatin organization. EMBO J. 3: 1737–1744.
Uemura, T., Morikawa, K., and Yanagida, M. 1986. The nucleo-
tide sequence of the fission yeast DNA topoisomerase II
gene: Structural and functional relationships to other DNA
topoisomerases. EMBO J. 5: 2355–2361.
Vagnarelli, P., Morrison, C., Dodson, H., Sonoda, E., Takeda, S.,
and Earnshaw, W.C. 2004. Analysis of Scc1-deficient cells
defines a key metaphase role of vertebrate cohesin in linking
sister kinetochores. EMBO Rep. 5: 167–171.
Vogel, C., Kienitz, A., Muller, R., and Bastians, H. 2005. The
mitotic spindle checkpoint is a critical determinant for to-
poisomerase-based chemotherapy. J. Biol. Chem. 280: 4025–
4028.
Wach, A., Brachat, A., Pohlmann, R., and Philippsen, P. 1994.
New heterologous modules for classical or PCR-based gene
disruptions in Saccharomyces cerevisiae. Yeast 10: 1793–
1808.
Wasserman, S.A. and Cozzarelli, N.R. 1986. Biochemical topol-
ogy: Applications to DNA recombination and replication.
Science 232: 951–960.
Weinert, T.A. and Hartwell, L.H. 1988. The RAD9 gene controls
the cell cycle response to DNA damage in S. cerevisiae. Sci-
ence 241: 317–322.
Winey, M., Mamay, C.L., O’Toole, E.T., Mastronarde, D.N.,
Giddings Jr., T.H., McDonald, K.L., and McIntosh, J.R. 1995.
Three-dimensional ultrastructural analysis of the Saccharo-
myces cerevisiae mitotic spindle. J. Cell Biol. 129: 1601–
1615.
Wood, E.R. and Earnshaw, W.C. 1990. Mitotic chromatin con-
densation in vitro using somatic cell extracts and nuclei
with variable levels of endogenous topoisomerase II. J. Cell
Biol. 111: 2839–2850.
Yanagida, M. and Wang, J.C. 1987. Yeast DNA topoisomerases
and their structural genes. In Nucleic acids and molecular
biology (eds. F. Eckstein and D.M.J. Lilley), pp. 196–209.
Springer-Verlag, Berlin and Heidelberg, Germany.
Zwelling, L.A., Mayes, J., Hinds, M., Chan, D., Altschuler, E.,
Carroll, B., Parker, E., Deisseroth, K., Radcliffe, A., Seligman,
M., et al. 1991. Cross-resistance of an amsacrine-resistant
human leukemia line to topoisomerase II reactive DNA in-
tercalating agents. Evidence for two topoisomerase II di-
rected drug actions. Biochemistry 30: 4048–4055.
Andrews et al.
1174 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on May 13, 2014 - Published by genesdev.cshlp.orgDownloaded from 
